Abbott Lab’s popular diet drug Meridia (sibutramine) may soon be off the U.S. market after a clinical study of nearly 10,000 patients showed that use of the drug increased the risk of heart attack or stroke in patients with underlying heart disease, and did little to...
On July 26-27, the Federal Communications Commission (FCC) and the Food and Drug Administration (FDA) hosted a series of public meetings to gain a better understanding of the convergence of communications technologies and medical devices, the future of wireless health...
The Federal Communications Commission (FCC) and the Food and Drug Administration (FDA) announced on July 26 a first-ever partnership to promote innovation and investment in wireless-enabled medical devices. In a joint statement, the federal agencies highlighted four primary...
In an increasingly online and mobile world, one of the biggest
concerns with the flow and availability of health information is the
reliability of it.
Speed vs. accuracy
has always been a concern with reporting, and it is a struggle to
strike a balance in providing...